Methods and compositions using norastemizole in combination with leukotriene inhibitors
US6372197B1 · kind B1 · utility
2Cited by
4References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 27, 2000 |
| Grant date | Apr 16, 2002 |
| Priority date | — |
| Expiry date | Nov 27, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods and pharmaceutical compositions employing norastemizole and a leukotriene inhibitor for the treatment or prevention of inflammation or allergic disorders, such as asthma or the symptoms thereof. Also included are methods and compositions employing norastemizole and a decongestant for the treatment or prevention of inflammation or allergic disorders, such as asthma or the symptoms thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.